Statement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings on "Follow-On Biopharmaceuticals"
- 1,102 views
Statement of Inger Mollerup, MSc ...
Statement of Inger Mollerup, MSc
Vice President Novo Nordisk A/S
Before the Government Oversight and Reform Committee Hearing On "Safe and Affordable Biotech Drugs - The Need for a Generic Pathway"
March 26, 2007
- Total Views
- Views on SlideShare
- Embed Views